Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid for Non-Healing Stress Fractures
NCT03576599Phase 4Terminated
- Sponsor
- Oslo University Hospital
- Start
- Jun 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in stress fracture, sponsored by Oslo University Hospital. Started Jun 2017; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
stress fracture
Beyond the preview
Go deeper on NCT03576599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03576599.